CN100376265C - Medicine for treating sterility - Google Patents

Medicine for treating sterility Download PDF

Info

Publication number
CN100376265C
CN100376265C CNB2006100675356A CN200610067535A CN100376265C CN 100376265 C CN100376265 C CN 100376265C CN B2006100675356 A CNB2006100675356 A CN B2006100675356A CN 200610067535 A CN200610067535 A CN 200610067535A CN 100376265 C CN100376265 C CN 100376265C
Authority
CN
China
Prior art keywords
portions
fructus
medicine
sterility
radix
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB2006100675356A
Other languages
Chinese (zh)
Other versions
CN1857520A (en
Inventor
胡福福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CNB2006100675356A priority Critical patent/CN100376265C/en
Publication of CN1857520A publication Critical patent/CN1857520A/en
Application granted granted Critical
Publication of CN100376265C publication Critical patent/CN100376265C/en
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention discloses a medicine for treating sterility, which comprises raw materials of 10 to 30 portions of human placenta, 10 to 30 portions of epimedium, 10 to 20 portions of wolfberry fruits, 5 to 15 portions of milkvetch seeds, 10 to 30 portions of glossy privet fruits, 5 to 15 portions of raspberries, 5 to 15 portions of schisandra, 5 to 15 portions of mulberry fruits, 5 to 15 portions of dodders, 10 to 30 portions of fleece-flower roots, 5 to 15 portions of unprocessed rehmannia roots, 10 to 30 portions of angelica and 5 to 15 portions of ural licorice root tips. The present invention is mainly suitable for male patients with sterility caused by oligospermatism, teratozoospermia and azoospermatism. The combination of various medicines has the efficiencies for tonifying the kidney, replenishing the essence, nourishing the liver, replenishing the spleen, promoting the generation of vital essence and blood and invigorating kidney yang. The medicine for treating sterility promotes the male sperm hyperplasia and enhances the sperm survival rate, and has the advantages of good curative effect, obvious effect, short time of therapy, low recurrence rate after cure and few side effects.

Description

The medicine of treatment infertility
Technical field
The present invention relates to a kind of medicine for the treatment of infertility, belong to the field of Chinese medicines.
Background technology
The Western medicine of treatment man oligospermatism mainly contains chorionic gona dotropin (HCG injection) clomiphene, zitazonium at present.This courses of pharmaceuticals lattice height that raises the price, its curative effect is low, and the traditional Chinese medical science thinks that the kidney being the origin of congenital constitution, the root of life.Therefore negative and positive that must conditioned kidney when treatment.
Summary of the invention
The object of the present invention is to provide a kind of medicine for the treatment of infertility.
The present invention makes raw materials of effective components and consists of,
1030 parts of Placenta Hominiss, Herba Epimedii 10-30 part, 1020 parts of Fructus Lycii, Semen Astragali Complanati 5-15 part, Fructus Ligustri Lucidi 10-30 part, Fructus Rubi 5-15 part, Fructus Schisandrae Chinensis 5-15 part, Fructus Mori 5-15 part, Semen Cuscutae 5-15 part, Radix Polygoni Multiflori 10-30 part, Radix Rehmanniae 5-15 part, Radix Angelicae Sinensis 10-30 part and Radix Glycyrrhizae uralensis 5-15 part.
The present invention mainly adapts to the oligospermatism that causes owing to the male, the patients with infertility of teratozoospermia, azoospermia.The main Placenta Hominis the kidney warming that adopts is mended essence, benefiting QI and nourishing blood.Be monarch drug, the promote the production of body fluid benefit that nourishes blood of Fructus Lycii, Semen Cuscutae, Fructus Ligustri Lucidi, Radix Polygoni Multiflori, Herba Epimedii kidney invigorating and YANG supporting, nourishing the liver strengthening the spleen, Radix Rehmanniae, Radix Angelicae Sinensis, Fructus Mori is smart, is ministerial drug altogether.Semen Astragali Complanati, Fructus Rubi, Fructus Schisandrae Chinensis, arresting seminal emission antidiarrheal are calmed the nerves and are adjuvant.Radix Glycyrrhizae uralensis is spleen reinforcing and coordinating the actions of various ingredients in a prescription, is messenger drug.All medicines share the effect of playing the invigorating kidney-YANG of enriching kidney essence nourishing the liver strengthening the spleen promoting generation of vital essence and blood altogether.Promote male's spermatogenesis, improve sperm survival rate.Have the curative effect height, instant effect, short treating period, the prognosis relapse rate is low, few side effects.
Curative effect: with these type of patient's 500 examples of we's treatment, cure 215 examples, account for 43%; Effective 152 examples account for 30.4%; Invalid 41 examples account for 8.2%; Total effective rate 91.8%.
The specific embodiment
The following examples can make those skilled in the art more fully understand the present invention, but do not limit the present invention in any way.
Embodiment 1
Take by weighing Placenta Hominis 10g, Herba Epimedii 10g, Fructus Lycii 10g, Semen Astragali Complanati 5g, Fructus Ligustri Lucidi 10g, Fructus Rubi 5g, Fructus Schisandrae Chinensis 5g, Fructus Mori 5g, Semen Cuscutae 5g, Radix Polygoni Multiflori 10, Radix Rehmanniae 5g, Radix Angelicae Sinensis 10g, Radix Glycyrrhizae uralensis 5g, every day, decocting three times was oral.Period in a medicine patient pure mind.The restraining sexual life.
Embodiment 2
Take by weighing Placenta Hominis 30g, Herba Epimedii 30g, Fructus Lycii 20g, Semen Astragali Complanati 15g, Fructus Ligustri Lucidi 30g, Fructus Rubi 15g, Fructus Schisandrae Chinensis 15g, Fructus Mori 15g, Semen Cuscutae 15g, Radix Polygoni Multiflori 30g, Radix Rehmanniae 15g, Radix Angelicae Sinensis 30g, Radix Glycyrrhizae uralensis 15g, every day, decocting three times was oral.Period in a medicine patient pure mind.The restraining sexual life.
Embodiment 3
Take by weighing Placenta Hominis 20g, Herba Epimedii 20g, Fructus Lycii 15g, Semen Astragali Complanati 10g, Fructus Ligustri Lucidi 20g, Fructus Rubi 10g, Fructus Schisandrae Chinensis 10g, Fructus Mori 10g, Semen Cuscutae 10g, Radix Polygoni Multiflori 20, Radix Rehmanniae 10g, Radix Angelicae Sinensis 20g, Radix Glycyrrhizae uralensis 10g, every day, decocting three times was oral.Period in a medicine patient pure mind.The restraining sexual life.

Claims (1)

1. medicine for the treatment of infertility, it is characterized in that: make raw materials of effective components and consist of, Placenta Hominis 10-30 part, Herba Epimedii 10-30 part, Fructus Lycii 10-20 part, Semen Astragali Complanati 5-15 part, Fructus Ligustri Lucidi 10-30 part, Fructus Rubi 5-15 part, Fructus Schisandrae Chinensis 5-15 part, Fructus Mori 5-15 part, Semen Cuscutae 5-15 part, Radix Polygoni Multiflori 10-30 part, Radix Rehmanniae 5-15 part, Radix Angelicae Sinensis 10-30 part and Radix Glycyrrhizae uralensis 5-15 part.
CNB2006100675356A 2006-03-02 2006-03-02 Medicine for treating sterility Expired - Fee Related CN100376265C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CNB2006100675356A CN100376265C (en) 2006-03-02 2006-03-02 Medicine for treating sterility

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CNB2006100675356A CN100376265C (en) 2006-03-02 2006-03-02 Medicine for treating sterility

Publications (2)

Publication Number Publication Date
CN1857520A CN1857520A (en) 2006-11-08
CN100376265C true CN100376265C (en) 2008-03-26

Family

ID=37296508

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB2006100675356A Expired - Fee Related CN100376265C (en) 2006-03-02 2006-03-02 Medicine for treating sterility

Country Status (1)

Country Link
CN (1) CN100376265C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105497731A (en) * 2014-11-30 2016-04-20 陈海明 Traditional Chinese medicine for treating oligospermia

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166377C (en) * 1999-11-01 2004-09-15 杜桂荣 Medicine for treating woman's acyesis
CN1686207A (en) * 2005-04-29 2005-10-26 胡春福 Ready prepared Chinese medicine for treating male sterility

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1166377C (en) * 1999-11-01 2004-09-15 杜桂荣 Medicine for treating woman's acyesis
CN1686207A (en) * 2005-04-29 2005-10-26 胡春福 Ready prepared Chinese medicine for treating male sterility

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
肾虚不孕症的中医临床研究进展. 曾锦蕙,张玉珍,罗颂平.中国中医基础医学杂志,第7卷第5期. 2001 *

Also Published As

Publication number Publication date
CN1857520A (en) 2006-11-08

Similar Documents

Publication Publication Date Title
CN103356961B (en) Traditional Chinese medicinal composition for treating amenorrhoea
CN101879276A (en) Health wine for invigorating kidney and strengthening yang
CN101884696A (en) Honeyed pill formulation capable of promoting hair to be regenerated and hair to become black
CN101366892A (en) Chinese medicinal composition for treating menorrhalgia
CN101433650B (en) Chinese medicinal composition for treating intermenstrual flow and dysmenorrhea
CN1457831A (en) Dynamic medicine for channels and collaterals and blood vessel
CN1772158A (en) Chinese medicine prepn for treating azoospermatism
CN102068661A (en) Chinese medical formula for treating female blood stasis, blood deficiency and deep thready pulse dysmenorrhea
CN101406656A (en) Medicament for treating hepatic cirrhosis with hypoproteinemia after hepatitis
CN104027461B (en) A kind of Chinese medicine composition treating urticaria
CN102697898A (en) Medicament for regulating endocrine and curing dysmenorrheal, mammary gland hyperplasia and breast dysplasia
CN104042902A (en) Traditional Chinese medicine composition for treating male infertility, and preparation method thereof
CN100376265C (en) Medicine for treating sterility
CN103356925B (en) Traditional Chinese medicine composition for treating sperm non-liquified symptom
CN1772162A (en) Chinese medicine prepn for treating immunological sterility
CN105998645A (en) Traditional Chinese medicine composition for treating leukotrichia and lipsotrichia
CN101745080A (en) Chinese patent medicine for treating leukemia
CN100339107C (en) Traditional Chinese medicine Zaisheng pills for treating gynaecological disease
CN101352508B (en) Chinese medicine for treating infertility and preparation method thereof
CN103316283A (en) Traditional Chinese medicinal composition for treating chronic cholecystitis, and preparation method thereof
CN101468143A (en) Chinese medicine composing prescription preparation for treating cardiac extra systole and method for preparing the same
CN102283974B (en) Oral liquid for curing female infertility
CN105456421A (en) Traditional Chinese medicinal composition for treating leukemia
CN104825720A (en) Traditional Chinese medicine composition for treating dysmenorrhoea
CN104958541A (en) Chinese medicinal composition for treating blood deficiency headache

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20080326

Termination date: 20120302